The imminent purchase by Wellington company, Volpara Health Technologies, of a Seattle medical software business will give Volpara, whose algorithms assist in the early detection of breast cancer, a substantial 27% market share in the US.
The ASX-listed Volpara, which is paying $A21.15 million
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
